Gene Targeting in Human Pluripotent Cells
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Mouse embryonic stem cells (mESCs) have the ability to differentiate into any cell type and can generate chimeric mice when transplanted into a host blastocyst. This remarkable potential, together with the development of robust gene targeting strategies in mESCs, were essential for establishing the mouse as the most widely used model organism in biomedical research. Recent advances have allowed the isolation of human embryonic stem cells and the derivation of induced pluripotent stem cells. Genetic tools similar to those proven routine in the mouse system are needed to realize the full potential of human pluripotent cells as disease models and putative therapeutics. Gene targeting in human cells, however, has proven to be more difficult, more time-consuming, and less robust than in mESCs. In this chapter, we discuss the strategies that have been used to allow specific genetic modifications in human pluripotent cells. We focus on the novel application of custom-engineered zinc-finger nucleases for gene targeting, which has promise to become a robust tool for efficient genetic manipulation of human pluripotent cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882 · cited 1×
“Whereas HR repairs the DSB with high fidelity, the second pathway, the nonhomologous end joining (NHEJ) pathway, fuses the broken ends in an error-prone fashion (Valerie and Povirk 2003; Lieber 2010).”
BackgroundGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
An improved zinc-finger nuclease architecture for highly specific genome editing
Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., Beausejour, C. M., Waite, A. J., Wang, N. S., Kim, K. A., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1319 · Cited by 1,051
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999 · cited 2×
“…et al. (2008) Gene addition PPP1R12C (AAVS1) Moehle et al. (2007) Dekelver et al. (2010) Gene correction IL2RG Urnov et al. (2005) Gene disruption Perez et al. (2008) Primary human cells Gene disruption, correction CCR5 Urnov et al. (2005) IL2RG Gene addition PPP1R12C (AAVS1) Moehle et al.…”
BackgroundMethodKnockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
Geurts, A. M., Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X., et al. (2009) · Science · doi:10.1126/science.1172447 · Cited by 934
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845 · cited 5×
“…et al. (2005) IL2RG Gene addition PPP1R12C (AAVS1) Moehle et al. (2007) Brunet et al. (2009) Dekelver et al. (2010) hESC/iPSCs Gene disruption IL2RG Lombardo et al. (2007) CCR5 PIGA Zou et al. (2009) Gene addition IL2RG Lombardo et al. (2007) CCR5 PIGA Zou et al. (2009) OCT4 up to ~90% Hockemeyer…”
BackgroundInfluentialChimeric nucleases stimulate gene targeting in human cells
Porteus, M. H., & Baltimore, D. (2003) · Science · doi:10.1126/science.1078395 · Cited by 741 · cited 3×
“This can result in gene targeting efficiencies of up to one in 10 cells undergoing a gene conversion (Bibikova et al. 2003; Porteus and Baltimore 2003).”
BackgroundCrystal Structure of a Five-Finger GLI-DNA Complex: New Perspectives on Zinc Fingers
Pavletich, N. P., & Pabo, C. O. (1993) · Science · doi:10.1126/science.8378770 · Cited by 669
DNA double-strand break repair: From mechanistic understanding to cancer treatment
HELLEDAY, T., LO, J., VANGENT, D., & ENGELWARD, B. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.006 · Cited by 640
Cited by
Human organoids: model systems for human biology and medicine
Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187
Genetic engineering of human pluripotent cells using TALE nucleases
Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1927 · Cited by 1,135
Self-citationInduced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499
“…implemented the use of SSNs such as ZFNs and transcription activator like effector nucleases (TALENs) to engineer hPSCs (DeKelver et al., 2010; Hockemeyer and Jaenisch, 2010; Hockemeyer et al., 2009; Hockemeyer et al., 2011; Lombardo et al., 2007; Sexton et al., 2014; Soldner et al., 2011;…”
MethodSelf-citationGonzález, F., Zhu, Z., Shi, Z.-D., Lelli, K., Verma, N., Li, Q. V., & Huangfu, D. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.05.018 · Cited by 503
Sebastiano, V., Maeder, M. L., Angstman, J. F., Haddad, B., Khayter, C., Yeo, D. T., Goodwin, M. J., Hawkins, J. S., Ramirez, C. L., Batista, L. F. Z., et al. (2011) · Stem Cells · doi:10.1002/stem.718 · Cited by 307
Mae, S.-I., Shono, A., Shiota, F., Yasuno, T., Kajiwara, M., Gotoda-Nishimura, N., Arai, S., Sato-Otubo, A., Toyoda, T., Takahashi, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms2378 · Cited by 291
Targeted gene disruption to cure HIV
Stone, D., Kiem, H.-P., & Jerome, K. R. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835f736c · Cited by 55
“Genes can be disrupted through introduction of precise ‘designer’ genomic deletions or additions, using gene-targeting techniques that rely upon homologous recombination (HR) between a targeted genomic sequence and an engineered DNA targeting vector (4-6).”
Stem cells and modeling of autism spectrum disorders
Freitas, B. C. G., Trujillo, C. A., Carromeu, C., Yusupova, M., Herai, R. H., & Muotri, A. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.017 · Cited by 27
“…(ZFN) or transcription activator-like effector nucleases (TALEN) can be used to manipulate the genome by exogenously introducing DNA fragments and correcting mutated genes via homologous recombination (Capecchi, 1989, Hockemeyer and Jaenisch, 2010, Lombardo, et al., 2007, Zou, et al., 2009).”
Background
Metadata
- Authors
- Hockemeyer, D., & Jaenisch, R.
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-01-01
- Volume
- 75
- Issue
- 0
- Pages
- 201-209
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- OpenAlex
- W2118918764
- Cited by
- 51
- References
- 11
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.